Huxley SANSA Home Sleep Apnea Test (1000-00) vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Tempus AI, Inc.

AI Verdict

Huxley SANSA is a wearable diagnostic tool for home sleep apnea and cardiac arrhythmias, providing multi-day physiological data through its proprietary patch. Tempus ECG-AF, conversely, is a software algorithm that analyzes standard 12-lead ECGs to predict the 12-month risk of new-onset atrial fibrillation in older patients. While both leverage AI in cardiology, Huxley focuses on direct diagnosis via a proprietary device, whereas Tempus offers a predictive risk assessment from existing clinical data.

Choose Huxley SANSA Home Sleep Apnea Test (1000-00) if…

Choose Huxley SANSA if your priority is a convenient, app-free, and multi-day home monitoring solution for both sleep apnea and cardiac arrhythmia diagnosis. This tool is ideal for patients who require comprehensive cardiosleep assessment in their natural environment, especially when remote monitoring and ease of use are paramount.

View Huxley SANSA Home Sleep Apnea Test (1000-00) →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your clinical practice aims to leverage existing 12-lead ECG data to proactively identify elderly patients (65+) at elevated risk of developing new-onset atrial fibrillation within the next year. This software solution is best suited for integration into healthcare facility systems to support earlier risk stratification and targeted follow-up for AF prevention.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Huxley SANSA Home Sleep Apnea Test (1000-00) Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment Cloud-native platform, accessible from any browser. Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA (Tool A) offers superior patient usability with its app-free, wearable chest patch design and built-in cellular data upload, eliminating common barriers like Bluetooth pairing or smartphone apps for home use. This streamlined approach simplifies the patient experience significantly.

Clinical Value

Huxley SANSA Home Sleep Apnea Test (1000-00)

While both tools are FDA-cleared and address important clinical needs, Huxley SANSA (Tool A) provides direct diagnostic capability for two significant conditions: home sleep apnea and cardiac arrhythmia, utilizing nine physiological data channels and validated against polysomnography. This offers a broader and more immediate diagnostic clinical utility compared to Tempus ECG-AF's (Tool B) risk prediction for future AF.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF (Tool B) explicitly states CMS reimbursement availability with specific CPT codes and a Medicare rate, providing a clear financial value proposition and pathway for adoption. Huxley SANSA (Tool A) only lists 'contact for pricing,' which offers less transparency regarding its economic value to healthcare providers.

Enterprise Readiness

Tempus ECG-AF

Tempus ECG-AF (Tool B) demonstrates stronger enterprise readiness through its explicit focus on deep integration with existing healthcare facility systems, including compatibility with major ECG vendors like GE and Philips, and robust EHR integrations for patient filtering and result delivery. This approach aligns well with established hospital workflows and large-scale clinical adoption.

Innovation

Huxley SANSA Home Sleep Apnea Test (1000-00)

Huxley SANSA (Tool A) presents a more significant innovation in remote diagnostics with its unique wearable patch form factor, app-free cellular data upload, and multi-day, multi-channel diagnostic capability for both sleep apnea and cardiac arrhythmias. This combines several advanced features into a single, patient-friendly home device.

Support & Docs

Tempus ECG-AF

Tempus ECG-AF (Tool B) offers a more comprehensive and structured approach to support and documentation, including a dedicated Document Library, a Resource Center with webinars and case studies, and explicit email support for inquiries. While Huxley SANSA (Tool A) mentions 24/7 live support for logistics, Tempus' broader range of accessible resources for clinical users and technical documentation is more robust.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Huxley SANSA Home Sleep Apnea Test (1000-00) Tempus ECG-AF
Name Huxley SANSA Home Sleep Apnea Test (1000-00) Tempus ECG-AF
Primary Use Case Home sleep apnea and cardiac arrhythmia diagnosis Identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months
Device Type/Data Input Wearable chest patch (9 physiological data channels: ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, Sleep/Wake Staging) AI-based algorithm analyzes 12-lead ECG recordings
Target Patient Population Not specified Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery
Key Technology AI-powered wearable patch AI-based algorithm for 12-lead ECG analysis
App-free Workflow Yes Not specified
Multi-day Monitoring Capability Yes Not specified
Reimbursement Details Contact for pricing CMS reimbursement available (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90, effective January 1, 2025)

Videos

Demos, reviews, and walkthroughs featuring Huxley SANSA Home Sleep Apnea Test (1000-00) and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Huxley SANSA is an FDA-cleared, AI-powered wearable patch for home sleep apnea and cardiac arrhythmia diagnosis. Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Huxley SANSA is intended for adults suspected of sleep apnea and cardiac disorders, for use in clinical and home settings. Tempus ECG-AF is specifically for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
Huxley SANSA uses a wearable chest patch that collects 9 physiological data channels, including ECG and SpO2, with built-in cellular data upload. Tempus ECG-AF is a software solution that analyzes existing 12-lead ECG recordings from compatible FDA authorized resting ECGs from GE Medical Systems and Philips Medical Systems.
Tempus ECG-AF has CMS reimbursement available, with CPT codes 0764T and 0765T assigned to APC 5734, at a Medicare rate of $128.90, effective January 1, 2025. Huxley SANSA's pricing is available upon contact, and the provided information does not specify dedicated reimbursement codes, though it aims to leverage existing billing codes for home sleep tests.
Huxley SANSA collects data from 9 physiological channels: ECG, SpO2, Heart Rate, Respiratory Effort, Chest Movement, Body Position, Actigraphy, Snoring, and Sleep/Wake Staging. Tempus ECG-AF analyzes 12-lead ECG recordings to detect signs associated with AF risk.
AI Tool Finder
AI-powered search. Results may not be comprehensive.